newsfilter
← Latest News
PR Newswire·

Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors

LEXINGTON, Mass., Oct. 16, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS) ("Curis" or the "Company"), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available,